Maryland 2026 Regular Session

Maryland House Bill HB633

Introduced
1/30/26  
Refer
1/30/26  
Report Pass
4/11/26  
Engrossed
4/13/26  

Caption

Health Insurance - Ovarian Cancer Prevention With Salpingectomy - Required Coverage

Impact

Upon enactment, the bill will apply to all health insurance policies issued, delivered, or renewed in Maryland starting January 1, 2027. This requirement is expected to have substantial implications for public health by increasing access to preventive measures against ovarian cancer. It aligns with broader efforts in healthcare to prioritize preventive care and may encourage more women to consider the procedure due to reduced financial barriers. The mandate reflects a growing recognition of the importance of proactive healthcare measures in reducing cancer risk.

Summary

House Bill 633 mandates that certain health insurance providers in Maryland include coverage for opportunistic salpingectomy as a preventive measure against ovarian cancer. This legislation requires that insurers, nonprofit health service plans, and health maintenance organizations provide this coverage without imposing any cost-sharing, such as copayments, coinsurance, or deductibles for the procedure. The law aims to support women's health by ensuring access to preventive surgical options that could significantly reduce the risk of ovarian cancer for individuals who opt for the procedure.

Sentiment

The general sentiment around HB633 appears to be supportive, particularly among health advocates and women's health organizations. Proponents emphasize the importance of increasing access to preventive health care measures for women, framing the bill as a critical step in safeguarding women's health. While there may be some concerns about cost implications for insurers, the overall discourse seems to focus on the health benefits provided by this mandated coverage and its potential to save lives through early intervention.

Contention

Despite the positive sentiment, there may be concerns from insurance providers about the financial implications of mandating coverage for salpingectomies without cost-sharing mechanisms. The discussion may touch upon the balance between ensuring comprehensive coverage for preventive care while managing the economic viability for insurers and health plans. Additionally, there could be debates regarding the definition of 'opportunistic' salpingectomy and the guidelines surrounding its implementation, which may generate varied opinions within the healthcare community.

Companion Bills

MD SB551

Crossfiled Health Insurance - Ovarian Cancer Prevention With Salpingectomy - Required Coverage and Prohibited Cost Sharing

Previously Filed As

MD SB518

Health Insurance - Screening for Ovarian Cancer - Required Coverage and Prohibited Cost Sharing

MD HB830

Health Insurance - Genetic Testing and Cancer Imaging - Required Coverage

MD SB476

Health Insurance - Genetic Testing and Cancer Imaging - Required Coverage and Prohibited Cost-Sharing

MD HB936

Health Insurance - Cancellation and Nonrenewal of Coverage - Required Notice

MD SB641

Health Insurance - Required Coverage - Hearing Aids

MD SB60

Maryland Medical Assistance Program and Health Insurance - Required Coverage for Calcium Score Testing

MD HB666

Maryland Medical Assistance Program and Health Insurance - Required Coverage for Calcium Score Testing

MD SB975

Health Insurance - Coverage for Specialty Drugs

MD SB374

Counties - Cancer Screening for Professional Firefighters - Required Coverage (James "Jimmy" Malone Act)

MD HB459

Counties - Cancer Screening for Professional Firefighters - Required Coverage (James "Jimmy" Malone Act)

Similar Bills

No similar bills found.